A role for glucocorticoids in severe COVID-19 respiratory failure [COVID-19]

• Research type

  Research Study

• Full title

  A role for glucocorticoids in severe COVID-19 respiratory failure\nCase-control study

• IRAS ID

  285681

• Contact name

  Timothy Woodhead

• Contact email

  t.woodhead1@nhs.net

• Sponsor organisation

  Kingston Hospital NHS Foundation Trust

• Duration of Study in the UK

  0 years, 3 months, 26 days

• Research summary

  Retrospective case-control study of data routinely collected by the intensive care unit whilst treating patients with COVID-19. The aim of the study is to analyse the effect of methylprednisolone treatment on outcome in patients with severe respiratory failure caused by COVID-19, with collection of demographic and comorbidity data to identify confounding or modifying effect.

• REC name

  N/A

• REC reference

  N/A